Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 15;6(2):141-143.
doi: 10.24875/RECIC.M24000441. eCollection 2024 Apr-Jun.

[One-year outcomes with the Firehawk sirolimus-eluting stent and biodegradable polymer guided by intravascular ultrasound]

[Article in Spanish]
Costantino Roberto Frack Costantini  1 , Marcos Antônio Denk  1 , Sergio Gustavo Tarbine  1 , Costantino Costantini Ortiz  1 , Vinicius Shibata Ferrari  1 , Rafael Michel de Macedo  1
Affiliations

[One-year outcomes with the Firehawk sirolimus-eluting stent and biodegradable polymer guided by intravascular ultrasound]

[Article in Spanish]
Costantino Roberto Frack Costantini et al. REC Interv Cardiol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

CONFLICTO DE INTERESES: Ninguno.

References

    1. Mintz GS. Features and parameters of drug-eluting stent deployment discoverable by intravascular ultrasound. Am J Cardiol. 2007;100(8B):26M-35M. - PubMed
    2. Mintz GS. Features and parameters of drug-eluting stent deployment discoverable by intravascular ultrasound. Am J Cardiol. 2007;100(8B):26M–35M. - PubMed
    1. Gao RL, Xu B, Lansky AJ, et al. A randomised comparison of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent:clinical and angiographic follow-up of the TARGET I trial. EuroIntervention. 2013;9:75-83. - PubMed
    2. Gao RL, Xu B, Lansky AJ, et al. A randomised comparison of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent:clinical and angiographic follow-up of the TARGET I trial. EuroIntervention. 2013;9:75–83. - PubMed
    1. Li C, Guan C, Zhang R, et al. Safety and efficacy of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent for the treatment of de novo coronary lesions:Final five-year results of the patient-level pooled analysis from the TARGET I and TARGET II trials. Catheter Cardiovasc Interv. 2019;93:818-24. - PubMed
    2. Li C, Guan C, Zhang R, et al. Safety and efficacy of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent for the treatment of de novo coronary lesions:Final five-year results of the patient-level pooled analysis from the TARGET I and TARGET II trials. Catheter Cardiovasc Interv. 2019;93:818–24. - PubMed
    1. Liu X, Tsujita K, Maehara A, et al. Intravascular ultrasound assessment of the incidence and predictors of edge dissections after drug-eluting stent implantation. JACC Cardiovasc Interv. 2009;2:997-1004. - PubMed
    2. Liu X, Tsujita K, Maehara A, et al. Intravascular ultrasound assessment of the incidence and predictors of edge dissections after drug-eluting stent implantation. JACC Cardiovasc Interv. 2009;2:997–1004. - PubMed

LinkOut - more resources